New Collaboration Offers Hope Of Parkinson’s Treatments

Eisai, a Japanese pharmaceutical company, and Wren Therapeutics, a spin-off company from the University of Cambridge in the UK and Lund University in Sweden, have announced an exclusive research collaboration agreement. The news that the two firms will be working together to further drug discovery for a range of conditions that involve synucleinopathies could bring hope to those suffering from …

Treatments To Be Fast-Tracked To UK Patients

Once the UK leaves the EU, the country will gain the autonomy for streamlining approval processes for medicines, joining other countries, such as the US, Canada, Australia, Switzerland, Singapore, and Brazil, in speeding up the approval of innovative medicines, including cancer treatments. According to GOV.UK press release, the UK will join two initiatives that will bring together some of the …